Article
A Cancer-Related microRNA Signature Shows Biomarker Utility in Multiple Myeloma
5 Dec 2021
Abstract excerpt
Multiple myeloma (MM) is the second most common hematological malignancy, arising from terminally differentiated B cells, namely plasma cells. miRNAs are small non-coding RNAs that participate in the post-transcriptional regulation of gene expression. In this study, we investigated the role of nine miRNAs in MM. CD138+ plasma cells were selected from bone marrow aspirates from MM and smoldering MM (sMM) patients....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
